SCHEMBL28865244

SCHEMBL28865244

Nc1nc(Nc2cccc(S(N)(=O)=O)c2)ncc1-c1ccc(Cc2nc[nH]n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 11/20 0.47
▸ CDK2 P24941 11/20 0.47
▸ CDK5 Q00535 7/20 0.47
▸ CCNT1 O60563 7/20 0.47
▸ CCNB1 P14635 7/20 0.47
▸ CDK9 P50750 7/20 0.47
▸ CCNA2 P20248 5/20 0.47
▸ CCNE1 P24864 4/20 0.47
▸ FLT3 P36888 3/20 0.47
▸ CDK5R1 Q15078 3/20 0.47
▸ CCND3 P30281 1/20 0.47
▸ CDK6 Q00534 1/20 0.47
▸ NTRK1 P04629 5/20 0.45
▸ JAK3 P52333 8/20 0.44
▸ AURKA O14965 5/20 0.44
▸ DCLK1 O15075 5/20 0.44
▸ AURKB Q96GD4 5/20 0.44
▸ SYK P43405 5/20 0.44
▸ PDPK1 O15530 4/20 0.44
▸ JAK2 O60674 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28246652 0.89 CDK1 (0.47) CDK1CDK2CCNT1CCNB1CDK9
SCHEMBL28059048 0.85 CDK1 (0.50) CDK1CDK2CDK5CCNT1CCNB1
Hydrochloric Acid SCHEMBL28247591 0.84 CDK1 (0.49) CDK1CDK2CDK5CCNT1CCNB1
SCHEMBL28247414 0.84 CDK1 (0.46) CDK1CDK2CDK5CCNT1CCNB1
SCHEMBL28246650 0.82 CDK2 (0.47) CDK1CDK2CDK5CCNT1CCNB1
SCHEMBL28247410 0.81 CDK1 (0.51) CDK1CDK2CDK5CCNT1CCNB1
SCHEMBL3999259 0.81 JAK3 (0.59) CDK1CDK2CDK5CCNT1CCNB1
SCHEMBL28246722 0.80 CDK1 (0.50) CDK1CDK2CDK5CCNT1CCNB1
SCHEMBL28956762 0.80 CDK2 (0.49) CDK1CDK2CDK5CCNT1CCNB1
SCHEMBL28247405 0.77 CDK1 (0.51) CDK1CDK2CDK5CCNT1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105348203-B Inhibit the composition and method of JAK approach 里格尔药品股份有限公司 2018-09-18 — — CN disclosed
Send feedback